Crossmark

Is denosumab an efficient and safe drug for osteoporosis in dialysis patients? Considerations and state of the art about its use in this setting

Published Online: 2024-06-10

Authors

Simonini, Marco https://orcid.org/0000-0003-0664-4600
Bologna, Arianna

Vezzoli, Giuseppe https://orcid.org/0000-0003-4481-5693
License Information

Text and Data Mining valid from 2024-06-10

Version of Record valid from 2024-06-10
More Information

Article History

Received: 9 April 2024

Accepted: 2 June 2024

First Online: 10 June 2024

Declarations

:

: The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

Document is current